[APLS] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
30-Mar-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -36.72%
YoY- -36.17%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -168,822 -50,574 -21,736 -9,051 -6,647 -3,969 -2,843 97.39%
Tax 3,933 340 267 -9,063 38 413 28 127.82%
NP -168,822 -50,574 -21,736 -9,051 -6,647 -3,555 -2,815 97.72%
Tax Rate - - - - - - - -
Total Cost 168,822 50,574 21,736 9,051 6,647 3,555 2,815 97.72%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -2.29 -0.87 -0.43 -0.50 -0.79 -0.78 -0.61 24.64%
EPS Diluted -2.29 -0.87 -0.43 -0.50 -0.79 -0.78 -0.61 24.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.